606 related articles for article (PubMed ID: 32816558)
21. Successful management of eosinophilic chronic rhinosinusitis complicated by severe asthma using dupilumab, following negative initial results with benralizumab.
Suzaki I; Tanaka A; Hirano K; Arai S; Kobayashi H
Allergol Int; 2021 Jan; 70(1):150-152. PubMed ID: 32507512
[No Abstract] [Full Text] [Related]
22. [Impact of reslizumab on the course of chronic rhinosinusitis in patients with eosinophilic asthma].
Boiko NV; Lodochkina OE; Kit MM; Kuleshova VG; Nedashkovskaya NG
Vestn Otorinolaringol; 2021; 86(2):43-48. PubMed ID: 33929151
[TBL] [Abstract][Full Text] [Related]
23. Real-Life Effectiveness of Benralizumab, Mepolizumab and Omalizumab in Severe Allergic Asthma Associated with Nasal Polyps.
Tiotiu A; Mendez-Brea P; Ioan I; Romero-Fernandez R; Oster JP; Hoang TC; Roux P; Ochoa-Gutierrez DC; Bonniaud P; de Blay F; Gonzalez-Barcala FJ
Clin Rev Allergy Immunol; 2023 Apr; 64(2):179-192. PubMed ID: 35420388
[TBL] [Abstract][Full Text] [Related]
24. Biologics for the Treatment of Allergic Rhinitis, Chronic Rhinosinusitis, and Nasal Polyposis.
Eschenbacher W; Straesser M; Knoeddler A; Li RC; Borish L
Immunol Allergy Clin North Am; 2020 Nov; 40(4):539-547. PubMed ID: 33012318
[TBL] [Abstract][Full Text] [Related]
25. Benefits of biologic therapy administered for asthma on co-existent chronic rhinosinusitis: A real-world study.
Bajpai S; Marino MJ; Rank MA; Donaldson AM; O'Brien EK; Lal D
Int Forum Allergy Rhinol; 2021 Aug; 11(8):1152-1161. PubMed ID: 33527730
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of omalizumab in nasal polyposis: 2 randomized phase 3 trials.
Gevaert P; Omachi TA; Corren J; Mullol J; Han J; Lee SE; Kaufman D; Ligueros-Saylan M; Howard M; Zhu R; Owen R; Wong K; Islam L; Bachert C
J Allergy Clin Immunol; 2020 Sep; 146(3):595-605. PubMed ID: 32524991
[TBL] [Abstract][Full Text] [Related]
27. Association of chronic rhinosinusitis with nasal polyps and asthma: clinical and radiological features, allergy and inflammation markers.
Staikūniene J; Vaitkus S; Japertiene LM; Ryskiene S
Medicina (Kaunas); 2008; 44(4):257-65. PubMed ID: 18469501
[TBL] [Abstract][Full Text] [Related]
28. Effect of Benralizumab in Patients With Severe Eosinophilic Asthma and Chronic Rhinosinusitis With Nasal Polyps: A Case Series.
Chitguppi C; Patel P; Gandler A; Murphy K; Khoury Md T; Monostra P; Bork S; Toskala E; Rabinowitz M; Rosen M; Nyquist G; Most J
Am J Rhinol Allergy; 2021 Sep; 35(5):559-567. PubMed ID: 33302694
[TBL] [Abstract][Full Text] [Related]
29. Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis.
Tsurumaki H; Matsuyama T; Ezawa K; Koga Y; Yatomi M; Aoki-Saito H; Chikamatsu K; Hisada T
Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31277327
[TBL] [Abstract][Full Text] [Related]
30. The Comorbid Patient in the Spotlight: Efficacy of Benralizumab on Chronic Rhinosinusitis with Nasal Polyp Outcomes in Presence of Severe Asthma.
De Corso E; D'Amato M; Carpagnano GE; Pelaia G; Bonini M
Curr Allergy Asthma Rep; 2023 May; 23(5):237-248. PubMed ID: 36995525
[TBL] [Abstract][Full Text] [Related]
31. Benralizumab strongly reduces blood basophils in severe eosinophilic asthma.
Lommatzsch M; Marchewski H; Schwefel G; Stoll P; Virchow JC; Bratke K
Clin Exp Allergy; 2020 Nov; 50(11):1267-1269. PubMed ID: 32762056
[No Abstract] [Full Text] [Related]
32. Switching of biological therapy to dupilumab in comorbid patients with severe asthma and CRSwNP.
Rosso C; De Corso E; Conti V; Nitro L; Saibene AM; Parazzini E; Rinaldo R; De Pascalis S; Arnone F; Centanni S; Montuori C; D'Auria LM; Felisati G; Pipolo C
Eur Arch Otorhinolaryngol; 2024 Jun; 281(6):3017-3023. PubMed ID: 38347197
[TBL] [Abstract][Full Text] [Related]
33. Doxycycline Improves Quality of Life and Anosmia in Chronic Rhinosinusitis With Nasal Polyposis: A Randomized Controlled Trial.
Nabavi M; Arshi S; Bemanian MH; Fallahpour M; Shokri S; Sabouri S; Moosavian F; Nazari J; Bakrani V; Atashrazm F
Am J Rhinol Allergy; 2023 Jul; 37(4):384-390. PubMed ID: 36740870
[TBL] [Abstract][Full Text] [Related]
34. Clinical Examination of Tissue Eosinophilia in Patients with Chronic Rhinosinusitis and Nasal Polyposis.
Gitomer SA; Fountain CR; Kingdom TT; Getz AE; Sillau SH; Katial RK; Ramakrishnan VR
Otolaryngol Head Neck Surg; 2016 Jul; 155(1):173-8. PubMed ID: 26980909
[TBL] [Abstract][Full Text] [Related]
35. Elevated Urine Leukotriene E4 Is Associated With Worse Objective Markers in Nasal Polyposis Patients.
Choby G; O'Brien EK; Smith A; Barnes J; Hagan J; Stokken JK; Strumpf A; Mattos JL; Payne SC; Divekar R
Laryngoscope; 2021 May; 131(5):961-966. PubMed ID: 33001452
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of Omalizumab in Severe Allergic Asthma and Nasal Polyposis: A Real-Life Study.
Tiotiu A; Oster JP; Roux PR; Nguyen Thi PL; Peiffer G; Bonniaud P; Dalphin JC; de Blay F
J Investig Allergol Clin Immunol; 2020; 30(1):49-57. PubMed ID: 30931917
[TBL] [Abstract][Full Text] [Related]
37. Role of tissue eosinophils in chronic rhinosinusitis-associated olfactory loss.
Hauser LJ; Chandra RK; Li P; Turner JH
Int Forum Allergy Rhinol; 2017 Oct; 7(10):957-962. PubMed ID: 28742240
[TBL] [Abstract][Full Text] [Related]
38. Favorable clinical efficacy of mepolizumab on the upper and lower airways in severe eosinophilic asthma: a 48-week pilot study.
Kurosawa M; Ogawa E; Sutoh E
Eur Ann Allergy Clin Immunol; 2019 Sep; 51(5):213-221. PubMed ID: 30983308
[No Abstract] [Full Text] [Related]
39. IL13 May Play an Important Role in Developing Eosinophilic Chronic Rhinosinusitis and Eosinophilic Otitis Media with Severe Asthma.
Shimizu H; Hayashi M; Kato H; Nakagawa M; Imaizumi K; Okazawa M
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681869
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of Benralizumab in severe asthma in real life and focus on nasal polyposis.
Bagnasco D; Brussino L; Bonavia M; Calzolari E; Caminati M; Caruso C; D'Amato M; De Ferrari L; Di Marco F; Imeri G; Di Bona D; Gilardenghi A; Guida G; Lombardi C; Milanese M; Nicolini A; Riccio AM; Rolla G; Santus P; Senna G; Passalacqua G
Respir Med; 2020 Sep; 171():106080. PubMed ID: 32917354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
